Toronto Dominion Bank’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-8,300
Closed -$2.32M 1927
2025
Q2
$2.32M Hold
8,300
﹤0.01% 937
2025
Q1
$2.59M Buy
+8,300
New +$2.45M 0.01% 872
2019
Q3
Sell
-16,000
Closed -$1.48M 1446
2019
Q2
$1.48M Buy
16,000
+11,000
+220% +$1.97M ﹤0.01% 886
2019
Q1
$950K Buy
5,000
+500
+11% +$95.5K ﹤0.01% 997
2018
Q4
$876K Buy
+4,500
New +$878K ﹤0.01% 921
2018
Q3
Sell
-14,200
Closed -$2.71M 1379
2018
Q2
$2.71M Buy
+14,200
New +$2.51M 0.01% 784
2017
Q2
Sell
-164,000
Closed -$26.9M 1201
2017
Q1
$26.9M Buy
164,000
+48,200
+42% +$8.01M 0.07% 136
2016
Q4
$16.9M Buy
+115,800
New +$17.4M 0.05% 145

Other funds holding AMGN

Toronto Dominion Bank's AMGN Position: Q1 2026 in Review

Toronto Dominion Bank reduced its Amgen (AMGN) stake by 15% in Q1 2026, selling an estimated $10.5M and leaving 166,826 shares worth $58.7M. The position accounts for 0.08% of the portfolio, ranked #210.

Toronto Dominion Bank first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $173M in Q4 2021. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Toronto Dominion Bank held 166,826 shares of Amgen worth $58.7M as of Q1 2026.
  • Toronto Dominion Bank sold 29,460 Amgen shares in Q1 2026, an estimated $10.5M.
  • Amgen made up 0.08% of Toronto Dominion Bank's portfolio in Q1 2026, its #210 holding.
  • Toronto Dominion Bank first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Toronto Dominion Bank's Amgen position peaked at $173M in Q4 2021.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.